Literature DB >> 19015651

How safe and effective is methylnaltrexone for the treatment of opioid-induced constipation in advanced illness?

Joseph Foss1.   

Abstract

Entities:  

Year:  2008        PMID： 19015651     DOI： 10.1038/ncpgasthep1315

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  5 in total

1.  Oral methylnaltrexone for opioid-induced constipation.

Authors:  C S Yuan; J F Foss
Journal:  JAMA       Date:  2000-09-20       Impact factor: 56.272

2.  Opioid side effects--mechanism-based therapy.

Authors:  Charles Berde; Samuel Nurko
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

3.  Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.

Authors:  Conor P Delaney; Bruce G Wolff; Eugene R Viscusi; Anthony J Senagore; John G Fort; Wei Du; Lee Techner; Bruce Wallin
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

4.  Methylnaltrexone for opioid-induced constipation in advanced illness.

Authors:  Jay Thomas; Sloan Karver; Gail Austin Cooney; Bruce H Chamberlain; Charles Kevin Watt; Neal E Slatkin; Nancy Stambler; Alton B Kremer; Robert J Israel
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

5.  The relationship between opioid use and laxative use in terminally ill cancer patients.

Authors:  N P Sykes
Journal:  Palliat Med       Date:  1998-09       Impact factor: 4.762
  5 in total
  1 in total

Review 1.  Laxatives for the management of constipation in people receiving palliative care.

Authors:  Bridget Candy; Louise Jones; Philip J Larkin; Victoria Vickerstaff; Adrian Tookman; Patrick Stone
Journal:  Cochrane Database Syst Rev       Date:  2015-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.